FoxA1 as a lineage-specific oncogene in luminal type breast cancer

Biochemical and Biophysical Research Communications

Volumn 365, Issue 4, 2008, Pages 711-717

  Yamaguchi, Noritaka ^a,b   Ito, Emi ^c   Azuma, Sakura ^b   Honma, Reiko ^c   Yanagisawa, Yuka ^c   Nishikawa, Akira ^c,d,e   Kawamura, Mika ^c,e   Imai, Jun ichi ^c,f   Tatsuta, Kuniaki ^a   Inoue, Jun ichiro ^b   Semba, Kentaro ^a,b   Watanabe, Shinya ^c,f  

^a WASEDA UNIVERSITY   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NIPPON GENE Co Ltd   (Japan)

^e Medicrome Inc   (Japan)

^f Japan Biological Information Research Center   (Japan)

Author keywords

Breast cancer; ER; ErbB2; FoxA1; RNAi

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR GATA 3; TRASTUZUMAB;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RNA INTERFERENCE; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; NEOPLASM PROTEINS; ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 36849044806     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.064     Document Type: Article

References (28)

1. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2 (2001) 127-137
2. Craven R.J., Lightfoot H., and Cance W.G. A decade of tyrosine kinases: from gene discovery to therapeutics. Surg. Oncol. 12 (2003) 39-49
3. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
4. Carter P., Presta L., Gorman C.M., Ridgway J.B., Henner D., Wong W.L., Rowland A.M., Kotts C., Carver M.E., and Shepard H.M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. USA 89 (1992) 4285-4289
5. Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., Sklarin N.T., Seidman A.D., Hudis C.A., Moore J., Rosen P.P., Twaddell T., Henderson I.C., and Norton L. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14 (1996) 737-744
6. Cobleigh M.A., Vogel C.L., Tripathy D., Robert N.J., Scholl S., Fehrenbacher L., Wolter J.M., Paton V., Shak S., Lieberman G., and Slamon D.J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17 (1999) 2639-2648
7. Vogel C., Cobleigh M.A., Tripathy D., Gutheil J.C., Harris L.N., Fehrenbacher L., Slamon D.J., Murphy M., Novotny W.F., Burchmore M., Shak S., and Stewart S.J. First-line, single-agent Herceptin(R) (trastuzumab) in metastatic breast cancer. A preliminary report. Eur. J. Cancer 37 1 (2001) 25-29
8. Carlsson P., and Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev. Biol. 250 (2002) 1-23
9. Kaestner K.H. The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism. Trends Endocrinol. Metab. 11 (2000) 281-285
10. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., and Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9 (2002) 279-289
11. Pani L., Overdier D.G., Porcella A., Qian X., Lai E., and Costa R.H. Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol. Cell Biol. 12 (1992) 3723-3732
12. Qian X., and Costa R.H. Analysis of hepatocyte nuclear factor-3 beta protein domains required for transcriptional activation and nuclear targeting. Nucleic Acids Res. 23 (1995) 1184-1191
13. Gao N., Zhang J., Rao M.A., Case T.C., Mirosevich J., Wang Y., Jin R., Gupta A., Rennie P.S., and Matusik R.J. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol. Endocrinol. 17 (2003) 1484-1507
14. Lin L., Miller C.T., Contreras J.I., Prescott M.S., Dagenais S.L., Wu R., Yee J., Orringer M.B., Misek D.E., Hanash S.M., Glover T.W., and Beer D.G. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 62 (2002) 5273-5279
15. Perou C.M., Jeffrey S.S., van de Rijn M., Rees C.A., Eisen M.B., Ross D.T., Pergamenschikov A., Williams C.F., Zhu S.X., Lee J.C., Lashkari D., Shalon D., Brown P.O., and Botstein D. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96 (1999) 9212-9217
16. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., and Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
17. Doane A.S., Danso M., Lal P., Donaton M., Zhang L., Hudis C., and Gerald W.L. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25 (2006) 3994-4008
18. Wolf I., Bose S., Williamson E.A., Miller C.W., Karlan B.Y., and Koeffler H.P. FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer. Int. J. Cancer 120 (2007) 1013-1022
19. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., and Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 (2005) 33-43
20. Laganiere J., Deblois G., Lefebvre C., Bataille A.R., Robert F., and Giguere V. From the Cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102 (2005) 11651-11656
21. Ito E., Honma R., Yanagisawa Y., Imai J., Azuma S., Oyama T., Ohwada S., Akiyama T., Nomura N., Inoue J., Watanabe S., and Semba K. Novel clusters of highly expressed genes accompany genomic amplification in breast cancers. FEBS Lett. 581 (2007) 3909-3914
22. Shih D.Q., Navas M.A., Kuwajima S., Duncan S.A., and Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc. Natl. Acad. Sci. USA 96 (1999) 10152-10157
23. Gao N., Ishii K., Mirosevich J., Kuwajima S., Oppenheimer S.R., Roberts R.L., Jiang M., Yu X., Shappell S.B., Caprioli R.M., Stoffel M., Hayward S.W., and Matusik R.J. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 132 (2005) 3431-3443
24. Besnard V., Wert S.E., Kaestner K.H., and Whitsett J.A. Stage-specific regulation of respiratory epithelial cell differentiation by Foxa1. Am. J. Physiol. Lung Cell Mol. Physiol. 289 (2005) L750-L759
25. Song E., Zhu P., Lee S.K., Chowdhury D., Kussman S., Dykxhoorn D.M., Feng Y., Palliser D., Weiner D.B., Shankar P., Marasco W.A., and Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005) 709-717
26. Kouros-Mehr H., Slorach E.M., Sternlicht M.D., and Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127 (2006) 1041-1055
27. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., Lindeman G.J., and Visvader J.E. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9 (2007) 201-209
28. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., Speed T., Spellman P.T., DeVries S., Lapuk A., Wang N.J., Kuo W.L., Stilwell J.L., Pinkel D., Albertson D.G., Waldman F.M., McCormick F., Dickson R.B., Johnson M.D., Lippman M., Ethier S., Gazdar A., and Gray J.W. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515-527